You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API tofacitinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing tofacitinib

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc	XELJANZ	tofacitinib	0069-1001	CELLULOSE, MICROCRYSTALLINE
Pfizer Laboratories Div Pfizer Inc	XELJANZ	tofacitinib	0069-1001	CROSCARMELLOSE SODIUM
Pfizer Laboratories Div Pfizer Inc	XELJANZ	tofacitinib	0069-1001	HYPROMELLOSE 2910
Pfizer Laboratories Div Pfizer Inc	XELJANZ	tofacitinib	0069-1001	LACTOSE MONOHYDRATE
Pfizer Laboratories Div Pfizer Inc	XELJANZ	tofacitinib	0069-1001	MAGNESIUM STEARATE
Pfizer Laboratories Div Pfizer Inc	XELJANZ	tofacitinib	0069-1001	POLYETHYLENE GLYCOL 3350
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for tofacitinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

tofacitinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

tofacitinib drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

tofacitinib drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

tofacitinib drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

tofacitinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 3350

tofacitinib drug variants containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

tofacitinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

tofacitinib drug variants containing TRIACETIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	tofacitinib	0069-1001
US Pharmaceuticals	tofacitinib	63539-012
>Company	>Ingredient	>NDC

tofacitinib drug variants not containing TRIACETIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.